Update: 14.06.2022
Last week: 22 week 2022 (30.05.2022 - 05.06.2022)
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 136 034 | -9.0% | 5.6% | 0.1 | 27 373 332 | -8.9% | 5.2% | 0.1 | -11.4% |
| YTD | 5 640 566 | 56.0% | 6.1% | 1.3 | 1 115 257 124 | 85.7% | 5.8% | 1.6 | 22.2% |
| MAT | 15 293 394 | 68.5% | 6.8% | 2 | 2 805 372 768 | 99.7% | 6.3% | 2.2 | 18.0% |
| DEXALGIN | |||||||||
| WoW | 35 659 | 1.8% | 0.9% | 0.1 | 15 140 929 | 3.3% | 2.2% | 0.2 | -4.7% |
| YTD | 955 070 | 39.0% | 0.8% | 0.1 | 393 354 777 | 51.3% | 2.1% | 0.4 | 17.8% |
| MAT | 2 107 078 | 8.8% | 0.7% | 0 | 834 343 606 | 16.6% | 2.0% | 0 | 7.4% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 90 764 | 1.2% | 64.9% | 4.2 | 46 362 992 | 1.6% | 71.3% | 4.4 | -5.3% |
| YTD | 2 429 525 | 12.7% | 63.3% | -10.5 | 1 222 292 109 | 28.2% | 70.3% | -8.2 | 31.4% |
| MAT | 5 555 844 | 13.0% | 66.9% | -5.5 | 2 693 849 520 | 29.1% | 74.1% | -4 | 22.2% |
| ESPUMISAN BABY | |||||||||
| WoW | 29 080 | 4.9% | 50.4% | 4.7 | 18 221 187 | 5.0% | 60.7% | 4.6 | -4.9% |
| YTD | 716 148 | -1.4% | 47.7% | -3.5 | 439 030 639 | 4.8% | 59.0% | -6 | 5.9% |
| MAT | 1 652 960 | -6.0% | 48.5% | -0.8 | 991 604 437 | 3.2% | 60.4% | -0.8 | -4.6% |
| FASTUM | |||||||||
| WoW | 18 078 | -11.1% | 0.5% | 0 | 9 310 462 | -10.3% | 1.2% | -0.1 | -6.3% |
| YTD | 552 900 | -11.5% | 0.7% | -0.1 | 278 378 531 | -2.8% | 1.6% | -0.4 | 5.7% |
| MAT | 1 313 407 | -12.6% | 0.7% | -0.1 | 632 267 750 | -5.0% | 1.7% | -0.3 | 2.0% |
| IODOMARIN | |||||||||
| WoW | 62 167 | 18.0% | 7.5% | 1.2 | 12 405 619 | 17.7% | 11.4% | 1.9 | -1.3% |
| YTD | 1 278 756 | 9.9% | 7.2% | 0.6 | 241 406 535 | 10.7% | 9.2% | 0.2 | 0.3% |
| MAT | 3 261 520 | 18.2% | 8.1% | 1.7 | 606 111 247 | 18.2% | 11.0% | 2 | -7.2% |
| LIOTON | |||||||||
| WoW | 25 736 | 4.2% | 2.6% | 0.2 | 26 732 458 | 3.4% | 4.7% | 0.4 | -5.4% |
| YTD | 669 758 | -3.4% | 2.9% | -0.1 | 671 890 321 | 22.2% | 5.1% | -0.1 | 0.5% |
| MAT | 1 668 804 | -4.9% | 3.1% | -0.1 | 1 524 879 819 | 13.9% | 5.6% | -0.1 | -2.8% |
| MEZYM | |||||||||
| WoW | 329 187 | -5.7% | 28.2% | 1.2 | 49 930 379 | -7.2% | 19.8% | 0 | -9.8% |
| YTD | 10 166 239 | 31.7% | 30.0% | 4 | 1 555 777 114 | 42.9% | 21.6% | 2 | 14.0% |
| MAT | 23 203 936 | 26.6% | 30.7% | 4 | 3 375 355 827 | 32.1% | 22.5% | 1.9 | 10.0% |
| MIG 400 | |||||||||
| WoW | 164 918 | 5.6% | 4.1% | 0.4 | 19 519 127 | 6.0% | 2.8% | 0.3 | -4.7% |
| YTD | 4 152 591 | 21.2% | 3.5% | 0.1 | 486 313 687 | 23.7% | 2.6% | -0.1 | 17.8% |
| MAT | 10 618 180 | 21.7% | 3.8% | 0.4 | 1 209 892 275 | 23.8% | 2.9% | 0.2 | 7.4% |
| PROSTAMOL | |||||||||
| WoW | 24 477 | -4.8% | 17.3% | 0.4 | 34 368 836 | -5.1% | 19.6% | 0.6 | -7.1% |
| YTD | 862 770 | -4.7% | 20.3% | -3.7 | 1 214 534 393 | 8.0% | 23.0% | -4.2 | 12.8% |
| MAT | 2 097 490 | -1.0% | 22.7% | -1.4 | 2 789 613 569 | 7.4% | 25.3% | -2.4 | 5.0% |
| RESPERO MYRTOL | |||||||||
| WoW | 15 872 | 1.1% | 7.6% | 0.7 | 7 509 341 | 1.1% | 7.2% | 0.5 | -8.2% |
| YTD | 663 371 | 246.2% | 9.3% | 6.2 | 308 452 488 | 233.1% | 9.0% | 5.5 | 13.7% |
| MAT | 1 218 586 | 115.7% | 7.9% | 3.6 | 560 716 284 | 102.6% | 7.8% | 2.8 | 16.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 640 566 | 56.0% | 6.1% | 1.3 | 1 115 257 124 | 85.7% | 5.8% | 1.6 | 22.2% |
| DEXALGIN | 955 070 | 39.0% | 0.8% | 0.1 | 393 354 777 | 51.3% | 2.1% | 0.4 | 17.8% |
| ESPUMISAN (ADULTS) | 2 429 525 | 12.7% | 63.3% | -10.5 | 1 222 292 109 | 28.2% | 70.3% | -8.2 | 31.4% |
| ESPUMISAN BABY | 716 148 | -1.4% | 47.7% | -3.5 | 439 030 639 | 4.8% | 59.0% | -6 | 5.9% |
| FASTUM | 552 900 | -11.5% | 0.7% | -0.1 | 278 378 531 | -2.8% | 1.6% | -0.4 | 5.7% |
| IODOMARIN | 1 278 756 | 9.9% | 7.2% | 0.6 | 241 406 535 | 10.7% | 9.2% | 0.2 | 0.3% |
| LIOTON | 669 758 | -3.4% | 2.9% | -0.1 | 671 890 321 | 22.2% | 5.1% | -0.1 | 0.5% |
| MEZYM | 10 166 239 | 31.7% | 30.0% | 4 | 1 555 777 114 | 42.9% | 21.6% | 2 | 14.0% |
| MIG 400 | 4 152 591 | 21.2% | 3.5% | 0.1 | 486 313 687 | 23.7% | 2.6% | -0.1 | 17.8% |
| PROSTAMOL | 862 770 | -4.7% | 20.3% | -3.7 | 1 214 534 393 | 8.0% | 23.0% | -4.2 | 12.8% |
| RESPERO MYRTOL | 663 371 | 246.2% | 9.3% | 6.2 | 308 452 488 | 233.1% | 9.0% | 5.5 | 13.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 15 293 394 | 68.5% | 6.8% | 2 | 2 805 372 768 | 99.7% | 6.3% | 2.2 | 18.0% |
| DEXALGIN | 2 107 078 | 8.8% | 0.7% | 0 | 834 343 606 | 16.6% | 2.0% | 0 | 7.4% |
| ESPUMISAN (ADULTS) | 5 555 844 | 13.0% | 66.9% | -5.5 | 2 693 849 520 | 29.1% | 74.1% | -4 | 22.2% |
| ESPUMISAN BABY | 1 652 960 | -6.0% | 48.5% | -0.8 | 991 604 437 | 3.2% | 60.4% | -0.8 | -4.6% |
| FASTUM | 1 313 407 | -12.6% | 0.7% | -0.1 | 632 267 750 | -5.0% | 1.7% | -0.3 | 2.0% |
| IODOMARIN | 3 261 520 | 18.2% | 8.1% | 1.7 | 606 111 247 | 18.2% | 11.0% | 2 | -7.2% |
| LIOTON | 1 668 804 | -4.9% | 3.1% | -0.1 | 1 524 879 819 | 13.9% | 5.6% | -0.1 | -2.8% |
| MEZYM | 23 203 936 | 26.6% | 30.7% | 4 | 3 375 355 827 | 32.1% | 22.5% | 1.9 | 10.0% |
| MIG 400 | 10 618 180 | 21.7% | 3.8% | 0.4 | 1 209 892 275 | 23.8% | 2.9% | 0.2 | 7.4% |
| PROSTAMOL | 2 097 490 | -1.0% | 22.7% | -1.4 | 2 789 613 569 | 7.4% | 25.3% | -2.4 | 5.0% |
| RESPERO MYRTOL | 1 218 586 | 115.7% | 7.9% | 3.6 | 560 716 284 | 102.6% | 7.8% | 2.8 | 16.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 136 034 | -9.0% | 5.6% | 0.1 | 27 373 332 | -8.9% | 5.2% | 0.1 | -11.4% |
| DEXALGIN | 35 659 | 1.8% | 0.9% | 0.1 | 15 140 929 | 3.3% | 2.2% | 0.2 | -4.7% |
| ESPUMISAN (ADULTS) | 90 764 | 1.2% | 64.9% | 4.2 | 46 362 992 | 1.6% | 71.3% | 4.4 | -5.3% |
| ESPUMISAN BABY | 29 080 | 4.9% | 50.4% | 4.7 | 18 221 187 | 5.0% | 60.7% | 4.6 | -4.9% |
| FASTUM | 18 078 | -11.1% | 0.5% | 0 | 9 310 462 | -10.3% | 1.2% | -0.1 | -6.3% |
| IODOMARIN | 62 167 | 18.0% | 7.5% | 1.2 | 12 405 619 | 17.7% | 11.4% | 1.9 | -1.3% |
| LIOTON | 25 736 | 4.2% | 2.6% | 0.2 | 26 732 458 | 3.4% | 4.7% | 0.4 | -5.4% |
| MEZYM | 329 187 | -5.7% | 28.2% | 1.2 | 49 930 379 | -7.2% | 19.8% | 0 | -9.8% |
| MIG 400 | 164 918 | 5.6% | 4.1% | 0.4 | 19 519 127 | 6.0% | 2.8% | 0.3 | -4.7% |
| PROSTAMOL | 24 477 | -4.8% | 17.3% | 0.4 | 34 368 836 | -5.1% | 19.6% | 0.6 | -7.1% |
| RESPERO MYRTOL | 15 872 | 1.1% | 7.6% | 0.7 | 7 509 341 | 1.1% | 7.2% | 0.5 | -8.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 TABS TUNIC 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 TABS TUNIC 400 MG #10"
## [1] "MIG 400 TABS TUNIC 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs